Related Experiment Video
Updated: Aug 5, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
In a nutshell review of hereditary antithrombin deficiency in pregnancy
Oluwatosin Afolabi1, Samuel Ruder2, Maria T DeSancho2
1Department of Internal Medicine, Weill Cornell Medicine, New York City, New York, USA.
Abstract:
Hereditary antithrombin deficiency is a high-risk thrombophilia associated with markedly increased maternal venous thromboembolism risk during pregnancy and postpartum. Individualized anticoagulation strategies with low-molecular-weight heparin, selective antithrombin concentrate replacement and multidisciplinary care optimize maternal and fetal outcomes.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rh Blood Group
Venous Thrombosis I: Introduction
Teratogenicity
